Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths Susmita Roy21 Oct 2025 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Biocon...
CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Susmita Roy21 Oct 2025 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted permission to...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
MSN Labs Gets SEC Nod for Roflumilast as Starting Dose in COPD Therapy Parthika Patel19 Oct 2025 12:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended the grant of permission to...
CDSCO Panel Flags Small Sample Size, Limited Scope, Asks Zydus to Rework Phase IV Letermovir Study Parthika Patel18 Oct 2025 6:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Zydus Lifesciences Ltd to...
CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study Parthika Patel17 Oct 2025 6:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott Healthcare Pvt. Ltd to...
CDSCO Panel Seeks More Clinical Data from Regenix Drugs on rDNA-Based Insulin Injection Susmita Roy16 Oct 2025 7:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has asked Regenix Drugs Ltd...
CDSCO Panel Clears BDR Pharma's Abiraterone Oral Suspension, Seeks Phase IV Trial Parthika Patel15 Oct 2025 4:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval for Abiraterone...
Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet Susmita Roy14 Oct 2025 5:23 PM ISTNew Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC), functioning under the Central Drug Standard Control...
Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab Parthika Patel14 Oct 2025 5:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has granted approval to Reliance Life...
SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar Parthika Patel12 Oct 2025 10:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked Enzene Biosciences Ltd to revise...
